Lorenzo Antonuzzo
12PUBLICATIONS
68CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Jul 07, 2025
Immune-mediated adverse events in the randomized phase 3 TOPAZ-1 study of durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer.Lorenzo Antonuzzo, Hidenori Takahashi, Joon Oh Park
|Jul 17, 2024
Delineation of gastrointestinal tumors biopsies using a fluorescence lifetime imaging optical fiber probe.D Suraci, E Baria, L Tirloni
|Feb 21, 2024
Exploiting Tertiary Lymphoid Structures to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy.Giulia Petroni, Serena Pillozzi, Lorenzo Antonuzzo
|Dec 05, 2023
Prognostic role of sodium levels in colorectal cancer patients receiving aflibercept plus FOLFIRI.Martina Catalano, Daniele Lavacchi, Elisa Giommoni
|Aug 11, 2023
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors.Talal El Zarif, Amin H Nassar, Gregory R Pond
|Apr 12, 2023
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study.Luca Cantini, Francesco Paoloni, Federica Pecci
Pageof 2
Frequent Collaborators
3 joint publications
Serena Pillozzi
2 joint publications
Giandomenico Roviello
1 joint publications
D Suraci
1 joint publications
E Baria
1 joint publications
L Tirloni
1 joint publications
J L Lagarto
1 joint publications
A Taddei
1 joint publications
R Cicchi
1 joint publications
Pamela Pinzani
1 joint publications
Giuseppe Procopio
